Molina Healthcare, Inc. (NYSE:MOH) Director John C. Molina sold 62,420 shares of the firm’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $72.13, for a total value of $4,502,354.60. Following the completion of the sale, the director now directly owns 393,410 shares of the company’s stock, valued at approximately $28,376,663.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
John C. Molina also recently made the following trade(s):
- On Thursday, January 18th, John C. Molina sold 16,226 shares of Molina Healthcare stock. The stock was sold at an average price of $92.49, for a total value of $1,500,742.74.
- On Monday, December 18th, John C. Molina sold 19,885 shares of Molina Healthcare stock. The stock was sold at an average price of $75.47, for a total value of $1,500,720.95.
Molina Healthcare, Inc. (NYSE:MOH) traded up $0.42 during midday trading on Thursday, reaching $71.56. The company’s stock had a trading volume of 799,549 shares, compared to its average volume of 1,419,657. Molina Healthcare, Inc. has a one year low of $42.56 and a one year high of $93.98. The company has a current ratio of 1.35, a quick ratio of 1.29 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $4,120.00, a price-to-earnings ratio of -8.86, a P/E/G ratio of 1.27 and a beta of 1.10.
MOH has been the subject of several recent research reports. Jefferies Group increased their price objective on Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a report on Friday, November 3rd. Goldman Sachs Group initiated coverage on Molina Healthcare in a report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price objective for the company. Morgan Stanley increased their price objective on Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, JPMorgan Chase & Co. cut their price objective on Molina Healthcare from $103.00 to $91.00 and set an “overweight” rating for the company in a report on Thursday, February 15th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. Molina Healthcare has a consensus rating of “Hold” and an average price target of $73.73.
COPYRIGHT VIOLATION NOTICE: This report was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://stocknewstimes.com/2018/02/22/insider-selling-molina-healthcare-inc-moh-director-sells-62420-shares-of-stock.html.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.